NASDAQ:FTH | Insider Transactions — Page 3 | Faeth Therapeutics, Inc.

FTH Insider Transactions — Page 3

398 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-27Purchase4,384.0$27.28
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-27Purchase4,384.0$27.28
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-27Purchase4,384.0$27.28
ENGLANDER ISRAEL ATenPercentOwner2026-03-27Purchase10,643.0$26.29
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-27Purchase10,643.0$26.29
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-27Purchase10,643.0$26.29
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-27Purchase10,643.0$26.29
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Sale1,274.0$28.69
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Sale1,274.0$28.69
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Sale1,274.0$28.69
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Sale1,274.0$28.69
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Sale583.0$26.88
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Sale583.0$26.88
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Sale583.0$26.88
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Sale583.0$26.88
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Purchase1,025.0$29.98
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Purchase1,025.0$29.98
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Purchase1,025.0$29.98
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Purchase1,025.0$29.98
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Purchase2,601.0$28.85
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Purchase2,601.0$28.85
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Purchase2,601.0$28.85
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Purchase2,601.0$28.85
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Purchase1,327.0$27.95
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Purchase1,327.0$27.95
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Purchase1,327.0$27.95
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Purchase1,327.0$27.95
ENGLANDER ISRAEL ATenPercentOwner2026-03-26Purchase778.0$27.23
MILLENNIUM MANAGEMENT LLCTenPercentOwner2026-03-26Purchase778.0$27.23
MILLENNIUM GROUP MANAGEMENT LLCTenPercentOwner2026-03-26Purchase778.0$27.23
ICS OPPORTUNITIES II LLCTenPercentOwner2026-03-26Purchase778.0$27.23
Cambrian BioPharma IncTenPercentOwner2025-12-09Sale446.0$7.92
Cambrian BioPharma IncTenPercentOwner2025-12-09Sale395.0$8.04
Cambrian BioPharma IncTenPercentOwner2025-12-09Sale2,666.0$7.95
Cambrian BioPharma IncTenPercentOwner2025-12-09Sale3,105.0$8.59
Peyer JamesTenPercentOwner,Other2025-12-09Sale446.0$7.92
Peyer JamesTenPercentOwner,Other2025-12-09Sale395.0$8.04
Peyer JamesTenPercentOwner,Other2025-12-09Sale2,666.0$7.95
Peyer JamesTenPercentOwner,Other2025-12-08Sale3,105.0$8.59
Cambrian BioPharma IncTenPercentOwner2025-12-05Sale42.0$13.16
Cambrian BioPharma IncTenPercentOwner2025-12-05Sale1,745.0$12.29
Cambrian BioPharma IncTenPercentOwner2025-12-05Sale14,508.0$11.4
Peyer JamesTenPercentOwner,Other2025-12-05Sale42.0$13.16
Peyer JamesTenPercentOwner,Other2025-12-05Sale1,745.0$12.29
Peyer JamesTenPercentOwner,Other2025-12-05Sale14,508.0$11.4
Cambrian BioPharma IncTenPercentOwner2025-12-04Sale5,000.0$9.06
Peyer JamesTenPercentOwner,Other2025-12-04Sale5,000.0$9.06
Celebi JohnPresident and CEO2023-09-11Purchase500.0$0.85
Presight Sensei Co-Invest Fund, L.P.Other2023-06-01Sale955,738.0$1.58
Apeiron Investment Group Ltd.TenPercentOwner2023-06-01Sale955,738.0$1.58
Angermayer ChristianTenPercentOwner2023-06-01Sale955,738.0$1.58
Presight Co-Invest Management, L.L.C.Other2023-06-01Sale955,738.0$1.58
Presight Sensei Co-Invest Fund, L.P.Other2023-06-01Sale2,485,923.0$1.58
Apeiron Investment Group Ltd.TenPercentOwner2023-06-01Sale2,485,923.0$1.58
Angermayer ChristianTenPercentOwner2023-06-01Sale2,485,923.0$1.58
Presight Co-Invest Management, L.L.C.Other2023-06-01Sale2,485,923.0$1.58
Presight Sensei Co-Invest Fund, L.P.Other2023-02-23Purchase1,100.0$1.6
Apeiron Investment Group Ltd.TenPercentOwner2023-02-23Purchase1,100.0$1.6
Angermayer ChristianTenPercentOwner2023-02-23Purchase1,100.0$1.6
Presight Co-Invest Management, L.L.C.Other2023-02-23Purchase1,100.0$1.6
Presight Sensei Co-Invest Fund, L.P.Other2023-02-23Purchase1,100.0$1.62
Apeiron Investment Group Ltd.TenPercentOwner2023-02-23Purchase1,100.0$1.62
Angermayer ChristianTenPercentOwner2023-02-23Purchase1,100.0$1.62
Presight Co-Invest Management, L.L.C.Other2023-02-23Purchase1,100.0$1.62
Peyer JamesDirector,TenPercentOwner2022-03-02Purchase1,203.0$3.2
Cambrian BioPharma IncTenPercentOwner2022-03-02Purchase1,203.0$3.2
Cambrian BioPharma IncTenPercentOwner2022-03-02Purchase1,203.0$3.2
Peyer JamesDirector,TenPercentOwner2022-03-02Purchase1,203.0$3.2
Peyer JamesDirector,TenPercentOwner2022-03-01Purchase2,458.0$3.6
Cambrian BioPharma IncTenPercentOwner2022-03-01Purchase2,458.0$3.6
Peyer JamesDirector,TenPercentOwner2022-02-28Purchase42.0$3.6
Cambrian BioPharma IncTenPercentOwner2022-02-28Purchase42.0$3.6
Peyer JamesDirector,TenPercentOwner2022-02-25Purchase2,500.0$3.65
Cambrian BioPharma IncTenPercentOwner2022-02-25Purchase2,500.0$3.65
Cambrian BioPharma IncTenPercentOwner2022-02-24Purchase15,000.0$3.63
Peyer JamesDirector,TenPercentOwner2022-02-24Purchase15,000.0$3.63
Cambrian BioPharma IncTenPercentOwner2022-02-23Purchase2,500.0$3.8
Peyer JamesDirector,TenPercentOwner2022-02-23Purchase2,500.0$3.8
Peyer JamesDirector,TenPercentOwner2022-02-18Purchase15,000.0$3.97
Cambrian BioPharma IncTenPercentOwner2022-02-18Purchase15,000.0$3.97
Peyer JamesDirector,TenPercentOwner2022-02-17Purchase4,949.0$4.17
Cambrian BioPharma IncTenPercentOwner2022-02-17Purchase4,949.0$4.17
Cambrian BioPharma IncTenPercentOwner2022-02-16Purchase2,551.0$4.25
Peyer JamesDirector,TenPercentOwner2022-02-16Purchase2,551.0$4.25
Cambrian BioPharma IncTenPercentOwner2022-02-14Purchase10,000.0$4.18
Peyer JamesDirector,TenPercentOwner2022-02-14Purchase10,000.0$4.18
Peyer JamesDirector,TenPercentOwner2022-02-11Purchase12,500.0$4.4
Cambrian BioPharma IncTenPercentOwner2022-02-11Purchase12,500.0$4.4
Peyer JamesDirector,TenPercentOwner2022-02-10Purchase5,000.0$4.58
Cambrian BioPharma IncTenPercentOwner2022-02-10Purchase5,000.0$4.58
Cambrian BioPharma IncTenPercentOwner2022-02-08Purchase10,000.0$4.33
Peyer JamesDirector,TenPercentOwner2022-02-08Purchase10,000.0$4.33
Cambrian BioPharma IncTenPercentOwner2022-02-04Purchase2,500.0$4.45
Peyer JamesDirector,TenPercentOwner2022-02-04Purchase2,500.0$4.45
Cambrian BioPharma IncTenPercentOwner2022-02-03Purchase17,500.0$4.65
Peyer JamesDirector,TenPercentOwner2022-02-03Purchase17,500.0$4.65
Cambrian BioPharma IncTenPercentOwner2022-01-28Purchase8,900.0$4.22
Peyer JamesDirector,TenPercentOwner2022-01-28Purchase8,900.0$4.22
Cambrian BioPharma IncTenPercentOwner2022-01-27Purchase6,100.0$4.31
Peyer JamesDirector,TenPercentOwner2022-01-27Purchase6,100.0$4.31